Secondary Logo

Share this article on:


JAIDS Journal of Acquired Immune Deficiency Syndromes: November 2014 - Volume 67 - Issue - p 3–12
doi: 10.1097/01.qai.0000456047.55809.85
Back to Top | Article Outline

16th Annual International Meeting of the Institute of Human Virology at the University of Maryland School of Medicine

Dear Colleagues and Friends,

Welcome to the 16th Annual Meeting of the Institute of Human Virology (IHV), scheduled for Sunday, September 14 through Wednesday, September 17. The Annual Meeting will feature themes on HIV Cure Research; HIV Pathogenesis; HIV Structural Biology, Immunology and Vaccines; Advances in Clinical, Prevention and Public Health Research, and a cross-cutting session on the Molecular and Immunological Insights from Cancer Biology and Treatment. In addition, Dr. Mark Kaplan from the University of Michigan will be presenting the first Reinhard Kurth Memorial Lecture. To provide opportunities for junior investigators to present we have emphasized submission of research abstracts through our web portal and have received an overwhelming response. As is our tradition, scientific leaders at the cutting edge of new advances will be presenting Special Lectures on important, emerging topics.

For 2014, our meeting returns to Baltimore and will be held at the Sheraton Inner Harbor Hotel located in the West Harbor area. The hotel is just a short distance from Camden Yards and M & T Stadium, the respective homes of the Baltimore Orioles and Ravens. Meeting participants will find a range of shopping, dining, and cultural venues in this bustling city locale.

This year we are proud to honor William Paul, MD, as the 2014 IHV Lifetime Achievement Awardee for Scientific Contributions to the field of immunology and pathogenesis. Dr. Paul is Chief of the Laboratory of Immunology at the National Institute of Allergy and Infectious Diseases (NIAID), and was former director of the NIH Office of AIDS Research (OAR). He is also the founding editor of the Annual Review of Immunology and a member of the National Academy of Sciences.

The 2014 Lifetime Achievement Award for Public Service is presented to John Martin, PhD. As Gilead's current Chief Executive Officer and Chairman of the Board, Dr. Martin is a leader in supporting access to life saving anti-HIV medications that, although still under patent, have been made widely and affordably available to the millions around the world infected with HIV and for prevention through Pre-exposure prophylaxis.

We look forward to welcoming you to Baltimore for the 16th Annual Meeting that continues the tradition of excellent science and provocative discussion.


Robert C. Gallo, MD


The Homer & Martha Gudelsky Distinguished Professor in MedicineProfessor of Microbiology and Immunology

Institute of Human Virology at The University of Maryland School of Medicine

Co-Founder and Scientific Director, Global Virus Network

William A. Blattner, MD

Professor and Associate DirectorInstitute of Human Virology

Back to Top | Article Outline

Mission Statement

The Institute of Human Virology (IHV) is a world-class center of excellence focusing on chronic viral diseases and virally linked cancers. IHV is dedicated to biomedical research leading to improved treatment and prevention of these diseases. Our unique structure connects cohesive, multidisciplinary research and clinical programs so that new treatments are streamlined from discovery to patients. IHV is forging local and international programs for research and treatment of human disease.

Robert C. Gallo, MD


Co-Director, Division of Basic Science and Vaccine Research

William A. Blattner, MD

Associate Director

Director, Division of Epidemiology and Prevention

Robert R. Redfield, MD

Associate Director

Director, Division of Clinical Care and Research

C. David Pauza, PhD

Associate Director of Faculty Development

George Lewis, PhD

Co-Director, Division of Basic Science and Vaccine Research

Joseph L. Bryant, DVM

Director, Division of Animal Models

Dave Wilkins

Chief Operating Officer

Institute of Human Virology (IHV) Board of Advisors

(Chair) Terry Lierman

Summit Global Ventures

Rockville, MD

Peter Angelos, Esquire

The Law Offices of Peter Angelos

Baltimore, MD

Robert Charrow, Esquire

Greenberg-Traurig, LLP

Washington, DC

Barbara J. Culliton

Science Journalist and Policy Consultant

Washington, DC

The Honorable Elijah Cummings

US House of Representatives

Washington, DC

John Evans

Evans Telecommunications

Ft. Lauderdale, FL

The Honorable Arthur J. Gajarsa

United States Court of Appeals for the Federal Circuit

Washington, DC

Stewart Greenebaum

Greenebaum & Rose Associates, Inc.

Baltimore, MD

William Hall, MD, PhD

University College Dublin

Centre for Research in Infectious Diseases

Dublin, Ireland

The Honorable Ernest F. Hollings

Medical University of South Carolina

Charleston, SC

Harry Huge

Chairman, Harry Huge Law Firm

Charleston, SC

Mark H. Kaplan, MD, FACP

University of Michigan Medical Center

Ann Arbor, MI

Sheilah Kast

WYPR Radio

College Park, MD

The Honorable Nancy Kopp

State Treasurer

Maryland State Government

Annapolis, MD

Ray Lewis

Ray Lewis Foundation

Hunt Valley, MD

Henry Lowe, PhD

Environmental Health Foundation

Bio-Tech R&D Institute, Ltd.

Kingston, Jamaica

Thomas Lynch

Amarin Pharmaceuticals, Ltd.

Dublin, Ireland

HRH Princess Chulabhorn Mahidol

Mahidol University

Bangkok, Thailand

Timothy Moynahan, Esquire

The Moynahan Law Firm, LLC

Waterbury, CT

Franco Nuschese

Georgetown Entertainment Group

Washington, DC

Joseph S. Pagano, MD

University of North Carolina, Chapel Hill

Chapel Hill, NC

Peter Palese, PhD

Mount Sinai School of Medicine

New York, NY

James Pinkerton

Co-Chair, RATE Coalition

Arlington, VA

Ellen Ratner

Bureau Chief, Talk News Radio

New York, NY

The Honorable Stephanie Rawlings-Blake

Baltimore City Mayor

Baltimore, MD

The Honorable Edward “Chip” Robertson, Jr.

Bartimus, Frickleton, Robertson & Gorny, P.C

Jefferson City, MO

Raj Shah

CTIS, Inc.

Rockville, MD

The Honorable Kathleen Kennedy-Townsend

Former Maryland Lieutenant Governor

Baltimore, MD

Jeffrey B. Trammell

Trammell and Company

Washington, DC

Coach Lenny Wilkens

National Basketball Association Hall of Fame Coach and Player

Medina, WA

Steve Wozencraft

John O'Donnell Associates, LLC

New York, NY

Back to Top | Article Outline

Organizing Committee

The Institute of Human Virology at the University of Maryland School of Medicine is grateful for the assistance provided by our International and Local Organizing Committees.

William Blattner, MD, Chair

Institute of Human Virology

Baltimore, Maryland, USA

Anders Vahlne, MD, PhD

Karolinska Institute

Stockholm, Sweden

Herve Fleury, MD, PhD

Bordeaux Segalen University

Bordeaux, France

Jose Esparza, MD, PhD

CHAVI Scientific Advisory Board Member

Seattle, Washington, USA

Warner Greene, MD, PhD

Gladstone Research Institutes

San Francisco, California, USA

Julie Overbaugh, PhD

Fred Hutchinson Cancer Research Center

Seattle, Washington, USA

John Niederhuber, MD

Inova Translational Medicine Institute

Falls Church, Virginia, USA

Merlin Robb, MD

Walter Reed Research Institute

Silver Spring, Maryland, USA

Antonino Carbone, MD

Istituto Nazionale dei Tumori

Milan, Italy

Carl Dieffenbach, PhD

National Institute of Allergy and Infectious Diseases

Bethesda, Maryland, USA

Luigi Buonaguro, MD

National Cancer Institute “Fondazione Pascale”

Naples, Italy

Back to Top | Article Outline

Local Organizing Committee

Institute of Human Virology

Baltimore, Maryland

Robert C. Gallo, MD, Chair

C. David Pauza, PhD, Co-Chair

Marvin Reitz, PhD, Co-Chair

Bruce Gilliam, MD

Man Charurat, PhD

Wuyuan Lu, PhD

Anthony DeVico, PhD

Anthony Amoroso, MD

Fabio Romerio, PhD

Back to Top | Article Outline

Communications and Press Policy

To enhance the exchange of information and communication among attendees of the Institute of Human Virology Annual International Meeting, the following must be adhered to by all participants:

  • All comments at sessions are off-the-record and are not for attribution.
  • No coverage, reporting or publication of scientific data or presentations at the Institute of Human Virology Annual Meeting is permitted without the written consent of the presenter(s) and Nora Grannell (info below). This rule applies to all forms of media, including blogging, tweeting, etc.
  • Alternatively, if the content does not contain information about non-published data, or comments made during the closed meeting, all forms of media are acceptable without written consent.

One-on-one interviews with scientists and media may be arranged by contacting Nora Grannell, Director of Public Relations and Marketing, Institute of Human Virology, (410) 706-1954 or

Those registering for the meeting as “press” must provide their credentials within 3 days to

Back to Top | Article Outline

Special Acknowledgements

The Institute of Human Virology at the University of Maryland would like to thank the following organizations. Without their continued and generous support, this meeting would not be possible.

National Institute of Allergy and Infectious Diseases*

National Institute on Drug Abuse

Office of AIDS Research

Division of AIDS, NIH

Sanofi Pasteur

Ortho Clinical Diagnostics

Profectus Biosciences, Inc.


The Marlene and Stewart Greenebaum Cancer Center



Travel On

Abbott Molecular



*Funding for this conference was made possible, in part, by Grant 2R13A1046078-12 from NIH. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services, nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Back to Top | Article Outline

2014 Lifetime Achievement Award for Scientific Contributions

William E. Paul, MD

William Paul is best known for his path-breaking work on cytokine biology including the discovery of interleukin-4, an extensive body of research on this cytokine that established it as the critical regulator of allergic inflammatory diseases and for establishing the mechanisms through which naïve CD4 T cells differentiate into Th effector cells. He has also made major contributions to the fields of T cell recognition of antigen, immunoglobulin class switching and B cell activation.

William Paul is Chief of the Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health and a National Institutes of Health Distinguished Investigator. From 1994 to 1997, he was Director of the NIH Office of the AIDS Research. During Paul's tenure as OAR Director, he was mainly responsible for a new emphasis on HIV vaccine research and development. He proposed and obtained resources for the creation of the Vaccine Research Center on the NIH campus.

Dr. Paul is a member of the U.S. National Academy of Sciences and of its Institute of Medicine. He is a fellow of the American Academy of Arts and Sciences. He received the 1980 Founder's Prize of the Texas Instruments Foundation, the 1988 Life Sciences Award from the Federation of American Societies for Experimental Biology, Lifetime Achievement Awards from the American Association of Immunologists and the International Cytokine Society, the 2008 Max Delbruck Medal and the 2009 Clemens von Pirquet Medal. He is a Raymond & Beverly Sackler Senior Professor by Special Appointment at Tel Aviv University and an Adjunct Professor of Pathology and Laboratory Medicine at the University of Pennsylvania School of Medicine. He served as editor-in-chief of the Annual Review of Immunology for its first 30 volumes and is the editor of the advanced textbook, Fundamental Immunology, the seventh edition of which has recently appeared.

Back to Top | Article Outline

2014 Lifetime Achievement Award for Public Service

John C. Martin, PhD

John C. Martin has served as chairman and CEO of Gilead Sciences since May 2008. He was president and CEO from April 1996 through May 2008. He joined the company in October 1990 as vice president for research and development. From 1984 to 1990, he was the head of antiviral chemistry at Bristol-Myers Squibb. Prior to that, he was with Syntex Corporation from 1978 to 1984. His research and career have focused on antiviral therapeutics, and he has contributed to the successful development of ganciclovir and cidofovir (CMV retinitis); oseltamivir (influenza); adefovir and tenofovir (hepatitis B); didanosine, stavudine, tenofovir, emtricitabine, Truvada, Atripla, Complera, and Stribild (HIV/AIDS); and Sovaldi® (hepatitis C).

Dr. Martin was President of the International Society for Antiviral Research from 1998 through 2000, Chairman of the Board of Directors of the BayBio—an industry organization—from 1999 through 2001, and Chairman of the Board of Directors of the California Healthcare Institute from 2005 through 2006 and 2009. He served on the National Institute of Allergy & Infectious Diseases Council from 2000 through 2003, on the Board of Directors of the Biotechnology Industry Organization from 2003 through 2005, on the Board of Directors of Gen-Probe Incorporated from 2007 through 2012, on the Board of Trustees of the University of Chicago from 2002 through 2008, on the Board of Trustees of the Golden Gate University from 2003 through 2006, and on the External Scientific Advisory Board of the University of California School of Global Health in 2008. Additionally, Dr. Martin served on the Centers for Disease Control/Health Resources and Services Administrations Advisory Committee on HIV and STD Prevention and Treatment from 2004 through 2007 and was a member of the Presidential Advisory Council on HIV/AIDS from 2006 through July of 2009. He is currently a member of the Board of Directors of California Healthcare Institute and also serves on the University of Southern California Board of Trustees.

Dr. Martin received a PhD in organic chemistry from the University of Chicago, an MBA in Marketing from Golden Gate University and a BS in chemical engineering from Purdue University. He received the Isbell Award of the American Chemical Society for his applications of carbohydrate chemistry to the design of medicinally active nucleosides and nucleotides. He also is the recipient of the International Society for Antiviral Research's Gertrude B. Elion award for Scientific Excellence. In 2008, he was inducted into the National Academy of Engineering of the National Academies.

Back to Top | Article Outline

Previous Recipients of IHV Lifetime Achievement Awards

Lifetime Achievement Awards for Scientific Contributions

1999 George Klein, PhD, Karolinska Institute, Stockholm, Sweden

2000 Maurice Hilleman, PhD, Merck Research Laboratories, Sumneytown, Pennsylvania

2001 Hilary Koprowski, MD, Thomas Jefferson University, Philadelphia, Pennsylvania

2002 Alexander Rich, PhD, Massachusetts Institute of Technology, Cambridge, Massachusetts

2003 Jan Svoboda, PhD, DSc, Institute of Molecular Genetics, Prague, Czech Republic

2004 Paul Zamecnik, MD, Massachusetts General Hospital, Boston, Massachusetts

2005 Manfred Eigen, PhD, Max Planck Institute, Gottingen, Germany

2006 Maxine Singer, PhD, National Institutes of Health, Bethesda, Maryland

2008 Isaac P. Witz, PhD, Tel Aviv University, Tel Aviv, Israel

2010 Rino Rappuoli, PhD, Novartis Vaccines, Sienna, Italy

2011 Max Essex, DVM, PhD, Harvard AIDS Institute, Boston, Massachusetts

2012 Thomas A. Waldmann, MD, National Institutes of Health, Bethesda, Maryland

2013 Vadim I. Agol, MD, PhD, DSc, Chumakov Institute, Moscow, Russian Federation

Back to Top | Article Outline

IHV Lifetime Achievement Award for Public Service

2004 Stewart Greenebaum, Greenebaum and Rose Associates, Inc., Baltimore, Maryland

2006 Martin Delaney, Project Inform, San Francisco, California

2008 John D Evans, Evans Telecommunication Company and The Honorable Robert K Gray, Gray and Company II, Miami, Florida

2010 Harry Huge, Esq, Charleston, South Caroline

2011 Bernadine Healy, MD, National Institutes of Health, Bethesda, Maryland

2012 Yi Zeng, PhD, China CDC, Beijing, China

2013 José Esparza, MD, PhD, The Bill & Melinda Gates Foundation, Seattle, Washington

Back to Top | Article Outline

One-Time IHV Lifetime Achievement Award for Excellence in Teaching

2010 Michele LaPlaca, MD, Bologna, Italy

Back to Top | Article Outline

IHV Lifetime Achievement Award for Excellence in Medical Education, Clinical Care and Clinical Research

2012 John G Bartlett, MD, Johns Hopkins School of Medicine, Baltimore, Maryland

© 2014 by Lippincott Williams & Wilkins